True and apparent inhibition of amyloid fibril formation

References

• Douglas PM, Treusch S, Ren H-Y, Halfmann R, Duennwald ML, Lindquist S, et al. Chaperone-dependent amyloid assembly protects cells from prion toxicity. Proc Natl Acad Sci U S A 2008; 105:7206 - 11; http://dx.doi.org/10.1073/pnas.0802593105; PMID: 18480252
   PubMed Web of Science ®Google Scholar
• Stöhr J, Weinmann N, Wille H, Kaimann T, Nagel-Steger L, Birkmann E, et al. Mechanisms of prion protein assembly into amyloid. Proc Natl Acad Sci U S A 2008; 105:2409 - 14; http://dx.doi.org/10.1073/pnas.0712036105; PMID: 18268326
   PubMed Web of Science ®Google Scholar
• Almstedt K, Nyström S, Nilsson KPR, Hammarström P. Amyloid fibrils of human prion protein are spun and woven from morphologically disordered aggregates. Prion 2009; 3:224 - 35; http://dx.doi.org/10.4161/pri.3.4.10112; PMID: 19923901
   PubMed Web of Science ®Google Scholar
• Uversky VN, Fink AL. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta. 2004; 1698:131-53.
   Google Scholar
• Bondos SE. Methods for measuring protein aggregation. Curr Anal Chem 2006; 2:157 - 70; http://dx.doi.org/10.2174/157341106776359140
   Web of Science ®Google Scholar
• Nilsson MR. Techniques to study amyloid fibril formation in vitro. Methods 2004; 34:151 - 60; http://dx.doi.org/10.1016/j.ymeth.2004.03.012; PMID: 15283924
   PubMed Web of Science ®Google Scholar
• Kim J, Kobayashi M, Fukuda M, Ogasawara D, Kobayashi N, Han S, et al. Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins. Prion 2010; 4:26 - 31; http://dx.doi.org/10.4161/pri.4.1.10889; PMID: 20083898
   PubMed Web of Science ®Google Scholar
• Charvériat M, Reboul M, Wang Q, Picoli C, Lenuzza N, Montagnac A, et al. New inhibitors of prion replication that target the amyloid precursor. J Gen Virol 2009; 90:1294 - 301; http://dx.doi.org/10.1099/vir.0.009084-0; PMID: 19264641
   PubMed Web of Science ®Google Scholar
• Giehm L, Otzen DE. Strategies to increase the reproducibility of protein fibrillization in plate reader assays. Anal Biochem 2010; 400:270 - 81; http://dx.doi.org/10.1016/j.ab.2010.02.001; PMID: 20149780
   PubMed Web of Science ®Google Scholar
• Sabaté R, Estelrich J. Stimulatory and inhibitory effects of alkyl bromide surfactants on β-amyloid fibrillogenesis. Langmuir 2005; 21:6944 - 9; http://dx.doi.org/10.1021/la050472x; PMID: 16008407
   PubMed Web of Science ®Google Scholar
• Klement K, Wieligmann K, Meinhardt J, Hortschansky P, Richter W, Fändrich M. Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer’s abeta(1-40) amyloid fibrils. J Mol Biol 2007; 373:1321 - 33; http://dx.doi.org/10.1016/j.jmb.2007.08.068; PMID: 17905305
   PubMed Web of Science ®Google Scholar
• Munishkina LA, Henriques J, Uversky VN, Fink AL. Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation. Biochemistry 2004; 43:3289 - 300; http://dx.doi.org/10.1021/bi034938r; PMID: 15023080
   PubMed Web of Science ®Google Scholar
• Sikkink LA, Ramirez-Alvarado M. Salts enhance both protein stability and amyloid formation of an immunoglobulin light chain. Biophys Chem 2008; 135:25 - 31; http://dx.doi.org/10.1016/j.bpc.2008.02.019; PMID: 18395318
   PubMed Web of Science ®Google Scholar
• White DA, Buell AK, Knowles TPJ, Welland ME, Dobson CM. Protein aggregation in crowded environments. J Am Chem Soc 2010; 132:5170 - 5; http://dx.doi.org/10.1021/ja909997e; PMID: 20334356
   PubMed Web of Science ®Google Scholar
• Ma Q, Fan J-B, Zhou Z, Zhou B-R, Meng S-R, Hu J-Y, et al. The contrasting effect of macromolecular crowding on amyloid fibril formation. PLoS One 2012; 7:e36288; http://dx.doi.org/10.1371/journal.pone.0036288; PMID: 22558423
   PubMedGoogle Scholar
• Kim HJ, Chatani E, Goto Y, Paik SR. Seed-dependent accelerated fibrillation of α-synuclein induced by periodic ultrasonication treatment. J Microbiol Biotechnol 2007; 17:2027 - 32; PMID: 18167451
   PubMed Web of Science ®Google Scholar
• Toschi F, Lugli F, Biscarini F, Zerbetto F. Effects of electric field stress on a β-amyloid peptide. J Phys Chem B 2009; 113:369 - 76; http://dx.doi.org/10.1021/jp807896g; PMID: 19063666
   PubMed Web of Science ®Google Scholar
• Crespo R, Rocha FA, Damas AM, Martins PM. A generic crystallization-like model that describes the kinetics of amyloid fibril formation. J Biol Chem 2012; 287:30585 - 94; http://dx.doi.org/10.1074/jbc.M112.375345; PMID: 22767606
   PubMed Web of Science ®Google Scholar
• Hammarström P, Wiseman RL, Powers ET, Kelly JW. Prevention of transthyretin amyloid disease by changing protein misfolding energetics. Science 2003; 299:713 - 6; http://dx.doi.org/10.1126/science.1079589; PMID: 12560553
   PubMed Web of Science ®Google Scholar
• Muchowski PJ, Wacker JL. Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 2005; 6:11 - 22; http://dx.doi.org/10.1038/nrn1587; PMID: 15611723
   PubMed Web of Science ®Google Scholar
• Hawkes CA, Deng L-H, Shaw JE, Nitz M, McLaurin J. Small molecule β-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer’s disease. Eur J Neurosci 2010; 31:203 - 13; http://dx.doi.org/10.1111/j.1460-9568.2009.07052.x; PMID: 20074226
   PubMed Web of Science ®Google Scholar
• Necula M, Kayed R, Milton S, Glabe CG. Small molecule inhibitors of aggregation indicate that amyloid β oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 2007; 282:10311 - 24; http://dx.doi.org/10.1074/jbc.M608207200; PMID: 17284452
   PubMed Web of Science ®Google Scholar
• Sievers SA, Karanicolas J, Chang HW, Zhao A, Jiang L, Zirafi O, et al. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation. Nature 2011; 475:96 - 100; http://dx.doi.org/10.1038/nature10154; PMID: 21677644
   PubMed Web of Science ®Google Scholar
• Masel J, Jansen VAA. Designing drugs to stop the formation of prion aggregates and other amyloids. Biophys Chem 2000; 88:47 - 59; http://dx.doi.org/10.1016/S0301-4622(00)00197-6; PMID: 11152275
   PubMed Web of Science ®Google Scholar
• Raman B, Chatani E, Kihara M, Ban T, Sakai M, Hasegawa K, et al. Critical balance of electrostatic and hydrophobic interactions is required for β 2-microglobulin amyloid fibril growth and stability. Biochemistry 2005; 44:1288 - 99; http://dx.doi.org/10.1021/bi048029t; PMID: 15667222
   PubMed Web of Science ®Google Scholar
• Yeh V, Broering JM, Romanyuk A, Chen B, Chernoff YO, Bommarius AS. The Hofmeister effect on amyloid formation using yeast prion protein. Protein Sci 2010; 19:47 - 56; PMID: 19890987
   PubMed Web of Science ®Google Scholar
• Baskakov IV, Bocharova OV. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features. Biochemistry 2005; 44:2339 - 48; http://dx.doi.org/10.1021/bi048322t; PMID: 15709746
   PubMed Web of Science ®Google Scholar
• Pronchik J, He X, Giurleo JT, Talaga DS. In vitro formation of amyloid from α-synuclein is dominated by reactions at hydrophobic interfaces. J Am Chem Soc 2010; 132:9797 - 803; http://dx.doi.org/10.1021/ja102896h; PMID: 20578692
   PubMed Web of Science ®Google Scholar
• Auer S, Ricchiuto P, Kashchiev D. Two-step nucleation of amyloid fibrils: omnipresent or not?. J Mol Biol 2012; 422:723 - 30; http://dx.doi.org/10.1016/j.jmb.2012.06.022; PMID: 22721952
   PubMed Web of Science ®Google Scholar
• Kashchiev D, Auer S. Nucleation of amyloid fibrils. J Chem Phys 2010; 132:215101; http://dx.doi.org/10.1063/1.3447891; PMID: 20528047
   PubMed Web of Science ®Google Scholar